recurrence

Experimental mRNA Vaccine Shows Landmark Success in Reducing Melanoma Recurrence and Death

A significant breakthrough in oncology has emerged from the Phase 3 INTerpath-001 clinical trial, where an experimental, personalized mRNA vaccine…